Benitec Biopharma Inc (BNTC) Return on Investment ROI from the fourth quarter of 2026 to fourth quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Benitec Biopharma Inc   (NASDAQ: BNTC)


Benitec Biopharma Inc's ROI from its fourth quarter of 2026 to the fourth quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Benitec Biopharma Inc's ROI in the fourth quarter of 2026?
Benitec Biopharma Inc recorded a cumulative net loss of $-46 million during 12 months ending in the fourth quarter of 2026, resulting in a negative return on investment (ROI) of -32.64%.

Within the Healthcare sector 378 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the third quarter of 2026 from 2947 to 3572.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
IV. Quarter		 (Mar 31 2026)
III. Quarter		 (Dec 31 2025)
II. Quarter		 (Sep 30 2025)
I. Quarter		 (Jun 30 2025)
IV. Quarter
Y / Y Investment Change TTM 81.09 % 84.27 % 128.32 % 173.65 % 276.5 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 182 184 98 94 98
Return On Investment (TTM) -32.64 % -35.04 % -45.36 % -49.48 % -49.21 %
BNTC's Overall Ranking # 3572 # 2947 # 2065 # 3402 #
Seq. Investment Change TTM 17.7 % 21.9 % 15.04 % 9.71 % 19.76 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -46 -42 -44 -42 -38

BNTC Company Profile >> Back to BNTC Roi Comparisons >> See Annual BNTC Return On Investment



Return On Investment BNTC's Ranking
Within: No.
Industry # 149
Sector # 379
Overall # 3572

Return On Investment Statistics
High Average Low
17.3 %
-129.74 %
-324.71 %
(Jun 30 2019)   (Jun 30 2023)



  News about Benitec Biopharma Inc Return on Investment ROI

Benitec Biopharma Inc Raises $40 Million in Oversubscribed Private Placement Financing, Fueling Groundbreaking Gene Therapy Advancements

April 18, 2024

Rejuvenated Investor Confidence Fuels Benitec Biopharma s Successful $40 Million Private Placement Financing
HAYWARD, Calif., April 18, 2024 – Benitec Biopharma Inc. (NASDAQ: BNTC), a clinical-stage biotechnology company specializing in gene therapy, proudly announced today the successful completion of an oversubscribed private investment in public equity (PIPE) financing, securing an impressive $40.0 million. This financing round exemplifies the increased investor confidence in Benitec s mission to develop revolutionary genetic medicines using their groundbreaking Silence and Replace DNA-directed RNA interference (ddRNAi) platform.
Leading this oversubscribed financing was Suvretta Capital Management, LLC, alongside a range of institutional accredited investors including Adage Capital Partners L.P., Nantahala Capital, several healthcare-focused funds, and a prominent mutual fund. The offering involved the sale of 5,749,152 shares of common stock at a price of $4.80 per share and pre-funded warrants granting the option to purchase an aggregate of 2,584,239 shares of common stock at a price of $4.7999 per pre-funded warrant.





Financial Statements
Benitec Biopharma Inc's IV. Quarter Investments $ 182 Millions BNTC's Balance sheet
Benitec Biopharma Inc's IV. Quarter Income $ -13 Millions Quarterly BNTC's Income Statement
BNTC's Income by Division See BNTC's Income by Division


BNTC Annual Return On Investment (Jun 30 2026)
2026		 (Jun 30 2025)
2025		 (Jun 30 2024)
2024		 (Jun 30 2023)
2023		 (Jun 30 2022)
2022
Total Investments in Millions 178 98 47 0 3
Y / Y Investment Growth 81.71 % 106.81 % 9629.63 % -85.88 % -82.8 %
Net Income in Millions -46 -38 -22 -20 -18
Y / Y Net Income Growth - - - - -
Annual Return On Investment -25.63 % -38.77 % -47.31 % -4025.1 % -529.15 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
BNTC's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for BNTC's Competitors
Subscribers only: Roi for Benitec Biopharma Inc's Suppliers
Subscribers only: Return On Investment for BNTC's Customers

Other Ratios
BNTC's Roa BNTC's Inventory Turnover Ratio BNTC's Growth Rates BNTC's Dividend Statistics
BNTC's Profitability Ratios BNTC's Asset Turnover Ratio BNTC's Dividend Growth
BNTC's Roe BNTC's Valuation Ratios BNTC's Financial Strength Ratios BNTC's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI

Date modified: 2026-09-15T11:48:00+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.